GlassScriptPrepare for your visit
Kenneth W Blumenthal
Family Medicine · Valparaiso, IN · NPI 1427053255
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$18,273.77
in general payments reported to CMS, 2019-2025 · $562 in 2025
The $562 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Who reported paying
General payments only, top 6 by amount.
- Pfizer INC. $11,568.17
- Astrazeneca Pharmaceuticals LP $1,696.46
- Glaxosmithkline, LLC. $1,026.21
- Regeneron Healthcare Solutions, INC. $988.44
- Genzyme Corporation $537.98
- Covis Pharma Gmbh $534.69
Drugs and devices associated with these payments
Dupixent Nucala Tezspire Fasenra Airsupra Xolair Trelegy Ellipta Cibinqo Hizentra Arexvy Breztri Xhance
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Kenneth Blumenthal listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/64852/kenneth-w-blumenthal